|
Post by nuklerfizzacist on Oct 1, 2015 9:02:39 GMT -5
I will be buying more...averaging down when i can.
|
|
|
Post by harryx1 on Oct 1, 2015 9:08:39 GMT -5
|
|
|
Post by kball on Oct 1, 2015 9:34:05 GMT -5
On the bright side...bet theres a willing bunch of migraine participants ready to go. Show of hands?
|
|
|
Post by babaoriley on Oct 1, 2015 9:40:21 GMT -5
"I'd be happy with $15/share and move on. "
nemzter - your happiness threshold is a whole lot higher than mine!
|
|
|
Post by nemzter on Oct 1, 2015 9:54:05 GMT -5
Is $15 too much to ask for?
Al, make it happen!!! LOL
|
|
|
Post by harrys on Oct 1, 2015 9:58:03 GMT -5
My recommendation is take three deep breaths, carefully re-read the actual article from the local business journal written by the political reporter and find something meaningful to focus on until the next quarterly earnings call. The use of the misleading headline words "third round" is the key. If it is deemed material by MNKD, a press release will appear. Unless that occurs, the lack of specifics in this report constitutes vague and unbalanced reporting that should be treated in the same way as other FUD. The short sided shills don't need our help. Danbury2015... never forget, never forgive.
|
|
|
Post by harrys on Oct 1, 2015 10:01:44 GMT -5
Is $15 too much to ask for? Al, make it happen!!! LOL I wish we could have a serious discussion on what we think Al would or could take the company private for, based on past experience investing? or experience in the private sector? $5 is my break even and considering the lack of opportunity cost in the broader market in the timeframe I've been invested, I wouldn't stand in Al's way if he went for >$5.
|
|
|
Post by harrys on Oct 1, 2015 10:16:51 GMT -5
I have no doubt this is the right move from a business perspective but from an optics perspective... it would seem MNKDs public view is like a horror movie where any and everything goes "wrong". I'm starting to think more seriously about the prospect of Al taking this company private for the sake of its own survival and to sever its fate from Wallstreet's cold greedy hands, in light of where the share price is now heading and with that thought in mind it's not good for a potential payday that we're currently flirting with the $2s. If Mann wanted to take the company private he would have done so a long time ago. I have never ever seen a patient look at the share price of the company before deciding to use a medication. Come to think of it I also have never seen a physician prescribe a medication based on share price. Mannkind will thrive or fail based on Afrezza and not on the short term share price. Why would Mann not taking the company private years ago have anything to do with him taking it private now when his legacy is struggling just before the finish line and it's at 52w lows? I have seen both the patient and physician shy from a product because of bad Public Image on CNBC and the like... the other faulty point in your argument is the fact that there will be no medication for the patient to take or the Doctor to prescribe if the company doesn't survive (or maybe Sanofi will buy up the scraps and make a killing off of the technology?). Again, the share price being divorced from the business is not a real thing except on this board in the minds of a few exuberant longs.
|
|
|
Post by Chris-C on Oct 1, 2015 10:17:49 GMT -5
Apparently nobody on this board was expecting this except myself and the newbie from the Sanofi Insulin thread who got torn to shreds... I think the writing was on the wall, but it says something about the jaded outlook and rose colored glasses on this board that YMB was able to provide this info as fact before anyone here would even consider it. Tisk tisk. Exactly harrys but the article was unfair and unbalanced! ;-) sarcasm. Anyone who says "who wasn't expecting this" should read this board and the comments again when the "rumor" first came out. oh and again now the article is written by a political guy and unbalanced, lol. But I feel fine since we are in a "soft" launch and everything is brilliant! Squirrel! ricguy Just re-read the eight posts you have put up since July - all pretty much negative and sarcastic in general. Question: Why bother to bash other people's opinions? Why not just sell and move on? ChrisC
|
|
|
Post by purge on Oct 1, 2015 10:19:06 GMT -5
Has everyone converted their shares to a Roth?
|
|
|
Post by mdcenter61 on Oct 1, 2015 10:19:59 GMT -5
Is $15 too much to ask for? Al, make it happen!!! LOL I wish we could have a serious discussion on what we think Al would or could take the company private for, based on past experience investing? or experience in the private sector? $5 is my break even and considering the lack of opportunity cost in the broader market in the timeframe I've been invested, I wouldn't stand in Al's way if he went for >$5.
Number one, I don't think Al is going to take this thing private at this point; he is "all in" with a billion dollar plus personal investment. Number two, a $5 price would invite at least twenty different New York ambulance chaser SEC firms to open up their "investigations" into MNKD practices, in my opinion. Personally, given his history, I don't think Al would do that to the shareholders. From a weary investor standpoint, yeah, if I got $10 I would take my meager profits and never venture into Biotech again!!
|
|
|
Post by compound26 on Oct 1, 2015 10:20:00 GMT -5
My recommendation is take three deep breaths, carefully re-read the actual article from the local business journal written by the political reporter and find something meaningful to focus on until the next quarterly earnings call. The use of the misleading headline words "third round" is the key. If it is deemed material by MNKD, a press release will appear. Unless that occurs, the lack of specifics in this report constitutes vague and unbalanced reporting that should be treated in the same way as other FUD. The short sided shills don't need our help. Chris, totally agree. Note what the last paragraph of the article says: Pfeffer noted that the company has closed its facility in Paramus, N.J. and moved certain functions from its Valencia, California, headquarters to the Danbury facility, which is located on Casper Street near the city’s downtown. A number of the local employees who have been laid off, he said, were short- term transfers from the New Jersey facility.
Others laid off at the California facility, he said, are being replaced with new hires at the Danbury plant.
|
|
|
Post by newmnkdinvestor on Oct 1, 2015 10:34:48 GMT -5
As some one who runs their own business I agree that you don't blow money on anything. Its a ll about the bottom line. I mail a lot of documents for my job. I ended up getting a stamp machine through stamp.com. I think the service was 15.99 a month. I can't remember what I had to pay for the stamp sheets but doing it at home was costing me more money. Maybe $25 bucks more. I said to myself the post office is right there. Why waste $25 and it was easier to just get them from the machine. Obviously 130 peoples salaries are a lot more money. I am starting to realize Matt is very good at spinning things in a manner that does not sound negative. I am going to see how this plays out the next couple of days but I have to much money out there based of early adopters reviews and the way everything has played out thats the only positive to really go off of. The 130 layoffs were in 2011 after the 2nd CRL. Here is the last line from yesterday's article. "Others laid off at the California facility, he said, are being replaced with new hires at the Danbury plant." Trading volume remains low this morning. Thanks for the correction I followed someones lead who posted that number in the thread.
|
|
|
Post by newmnkdinvestor on Oct 1, 2015 10:36:40 GMT -5
On the bright side...bet theres a willing bunch of migraine participants ready to go. Show of hands? Lol- I could use something for my stomach.
|
|
|
Post by mssciguy on Oct 1, 2015 10:41:56 GMT -5
FWIW, many big pharmas continuously lay off people. They call it "reallocation" but it's just the Jack Welsh style of management, always trimming trimming trimming...
|
|